How many clinical trials are there for GATA2 Deficancy?

PlainTrial tracks 1 US clinical trials for GATA2 Deficancy, of which 1 are currently recruiting.

How do I find a recruiting trial for GATA2 Deficancy?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

GATA2 Deficancy clinical trials

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed GATA2 Deficancy trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

GATA2 Deficancy: 1 US clinical trial tracked, 1 recruiting.

GATA2 Deficancy is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is National Cancer Institute (NCI), running 1 of these trials.

Enrollment posture brief

Registry condition gata2-deficancy

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near GATA2 Deficancy

GATA2 Deficancy lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for GATA2 Deficancy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

GATA2 Deficancy is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING 7 participants

Apheresis of Patients With Immunodeficiency

National Cancer Institute (NCI)

NCT01212055

Phase Distribution

Phase data not available

Top Sponsors

National Cancer Institute (NCI) 1 trials

US sites by state

Facility locations filed on GATA2 Deficancy trials. A trial with sites in several states counts in each.

Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this GATA2 Deficancy page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 GATA2 Deficancy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
National Cancer Institute (NCI) sponsors the most GATA2 Deficancy trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This GATA2 Deficancy condition card totals 1 registered trials; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.